127
Views
9
CrossRef citations to date
0
Altmetric
Review

Clinical evaluation of dimethyl fumarate for the treatment of relapsing-remitting multiple sclerosis: efficacy, safety, patient experience and adherence

&
Pages 1655-1666 | Published online: 01 Oct 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Larissa Hauer & Johann Sellner. (2022) Diroximel Fumarate as a Novel Oral Immunomodulating Therapy for Relapsing Forms of Multiple Sclerosis: A Review on the Emerging Data. Drug Design, Development and Therapy 16, pages 3915-3927.
Read now
Ana Rodríguez-Regal, Laura Ramos-Rúa, Luis Anibarro-García, Ana María Lopez Real & María del Campo Amigo-Jorrín. (2021) Effectiveness of Dimethyl Fumarate in Real-World Clinical Practice and Strategy to Minimize Adverse Effects and Use of Healthcare Resources. Patient Preference and Adherence 15, pages 149-158.
Read now

Articles from other publishers (7)

Bing Yang, Robert B. Parker, Bernd Meibohm, Zaid H. Temrikar, Ashish Srivastava & S. Casey Laizure. (2022) Alcohol inhibits the metabolism of dimethyl fumarate to the active metabolite responsible for decreasing relapse frequency in the treatment of multiple sclerosis. PLOS ONE 17:11, pages e0278111.
Crossref
Yuying Jiang, Yongbing Yang, Yingchao Hu, Rui Yang, Jiajia Huang, Yi Liu, Yuqing Wu, Sheng Li, Chunmei Ma, Fiachra Humphries, Bingwei Wang, Xi Wang, Zhibin Hu & Shuo Yang. (2022) Gasdermin D restricts anti-tumor immunity during PD-L1 checkpoint blockade. Cell Reports 41:4, pages 111553.
Crossref
Zhenzhen Zhai, Yanxin Huang, Yawei Zhang, Lili Zhao & Wen Li. (2022) Clinical Research Progress of Small Molecule Compounds Targeting Nrf2 for Treating Inflammation-Related Diseases. Antioxidants 11:8, pages 1564.
Crossref
Israa M. Abd El-Fatah, Heba M.A. Abdelrazek, Sherehan M. Ibrahim, Dalaal M. Abdallah & Hanan S. El-Abhar. (2021) Dimethyl fumarate abridged tauo-/amyloidopathy in a D-Galactose/ovariectomy-induced Alzheimer's-like disease: Modulation of AMPK/SIRT-1, AKT/CREB/BDNF, AKT/GSK-3β, adiponectin/Adipo1R, and NF-κB/IL-1β/ROS trajectories. Neurochemistry International 148, pages 105082.
Crossref
Roshan Lal, Jatinder Dhaliwal, Navneet Dhaliwal, Ravinder Naik Dharavath & Kanwaljit Chopra. (2021) Activation of the Nrf2/HO-1 signaling pathway by dimethyl fumarate ameliorates complete Freund's adjuvant-induced arthritis in rats. European Journal of Pharmacology 899, pages 174044.
Crossref
Giorgia Maniscalco, Vincenzo Brescia Morra, Ciro Florio, Giacomo Lus, Gioacchino Tedeschi, Maddalena Cianfrani, Renato Docimo, Stefania Miniello, Felice Romano, Leonardo Sinisi, Daniele Spitaleri, Giuseppe Longo, Ugo Trama, Maria Triassi, Cristina Scavone & Annalisa Capuano. (2020) Preliminary Results of the FASM Study, an On-Going Italian Active Pharmacovigilance Project. Pharmaceuticals 13:12, pages 466.
Crossref
Ming-xuan Wang, Jing Zhao, Hong Zhang, Ke Li, Ling-zhi Niu, Yuan-ping Wang & Ya-juan Zheng. (2020) Potential Protective and Therapeutic Roles of the Nrf2 Pathway in Ocular Diseases: An Update. Oxidative Medicine and Cellular Longevity 2020, pages 1-22.
Crossref